Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review

被引:18
|
作者
Mauriello, Claudio [1 ]
Napolitano, Salvatore [3 ]
Gambardella, Claudio [1 ]
Candela, Giancarlo [1 ]
De Vita, Ferdinando [2 ]
Orditura, Michele [2 ]
Sciascia, Valerio [1 ]
Tartaglia, Ernesto [1 ]
Lanza, Michele [1 ]
Santini, Luigi [1 ]
Conzo, Giovanni [1 ]
机构
[1] Univ Naples 2, Sch Med, Dept Anaesthesiol Surg & Emergency Sci, Unit Gen & Oncol Surg, I-80131 Naples, Italy
[2] Univ Naples 2, Sch Med, Dept Clin & Expt Med, Div Oncol, I-80131 Naples, Italy
[3] Minist Def, Italian Air Force Med Corps, Rome, Italy
关键词
Pancreatic neuroendocrine tumors; Conservative management; Parenchyma-sparing resections; Intraoperative ultrasonography; Thompson procedure; MULTIPLE-ENDOCRINE-NEOPLASIA; HIPPEL-LINDAU-DISEASE; SURGICAL-MANAGEMENT; INJECTION TEST; SURGERY; TYPE-1; GUIDELINES; CANCER;
D O I
10.1016/j.ijsu.2015.04.089
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Pancreatic neuroendocrine tumors (pNETs) are uncommon entities. pNETs are often small, slow growing, clinically silent neoplasms. However, they have an almost unpredictable biological behaviour with a not negligible malignant potential. Surgery still represents the treatment of choice, but the high morbidity associated to the enucleation or the formal pancreatectomy should be considered in the decision of the proper treatment. Management of these neoplasms is still debated, and indications for a conservative observational approach and for parenchyma sparing resections are not yet standardized. Method: We review the state of art on the indications for the conservative management of pNETs. Searches on MEDLINE database were performed to identify articles reporting prognostic systems, biochemical screening, observational management, medical treatment and surgical strategies for pNETs. Discussion: Currently, an accurate 'wait-and-see' policy is recommended by the European Neuroendocrine Tumor Society (ENETS) only for non-functioning pNETs (NF-pNETs) <2 cm. A biochemical screening, based on sampling of serum levels of pancreatic polypeptide (PP) and chromogranin A, can address to early conservative surgery for MEN-1 associated NF-pNETs <2 cm to prevent their malignant transformation. The subtotal (80%) distal pancreatectomy first proposed by Thompson, often with the enucleation of possible pancreatic head tumors, still represents a good compromise between oncological radicality and prevention of pancreatic endocrine/exocrine insufficiency caused by standard radical resections for the treatment of inherited syndromes associated with NF-pNETs >2 cm and symptomatic F-pNETs of any size. Conclusion: More studies are needed to further clarify and predict the biologic behaviour of pNETs and increase the indications for conservative observational management and parenchyma sparing pancreas resections. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S10 / S14
页数:5
相关论文
共 50 条
  • [41] Ampullary and Pancreatic Neuroendocrine Tumors: A Series of Cases and Review of the Literature
    Matli, Venkata Vinod Kumar
    Wellman, Gregory
    Jaganmohan, Sathya
    Koticha, Kirtan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [42] Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors
    Falconi, Massimo
    Zerbi, Alessandro
    Crippa, Stefano
    Balzano, Gianpaolo
    Boninsegna, Letizia
    Capitanio, Vanessa
    Bassi, Claudio
    Di Carlo, Valerio
    Pederzoli, Paolo
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1621 - 1627
  • [43] Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors
    Massimo Falconi
    Alessandro Zerbi
    Stefano Crippa
    Gianpaolo Balzano
    Letizia Boninsegna
    Vanessa Capitanio
    Claudio Bassi
    Valerio Di Carlo
    Paolo Pederzoli
    Annals of Surgical Oncology, 2010, 17 : 1621 - 1627
  • [44] Parenchyma-sparing, local pancreatic head resection for premalignant and low-malignant neoplasms - A systematic review and meta-analysis
    Beger, Hans G.
    Mayer, Benjamin
    Poch, Bertram
    AMERICAN JOURNAL OF SURGERY, 2018, 216 (06): : 1182 - 1191
  • [45] Benign Tumors of the Pancreas—Radical Surgery Versus Parenchyma-Sparing Local Resection—the Challenge Facing Surgeons
    Hans G. Beger
    Journal of Gastrointestinal Surgery, 2018, 22 : 562 - 566
  • [46] Management of Pancreatic Neuroendocrine Tumors
    Dickson, Paxton V.
    Behrman, Stephen W.
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (03) : 675 - +
  • [47] Management of pancreatic neuroendocrine tumors
    Keutgen, Xavier M.
    Babic, Bruna
    Nilubol, Naris
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2016, 3 (03) : 267 - 277
  • [48] Management of pancreatic neuroendocrine tumors
    Waller, E.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (01) : 57 - 65
  • [49] Management of Pancreatic Neuroendocrine Tumors
    Halperin, Daniel M.
    Kulke, Matthew H.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (01) : 119 - +
  • [50] Pancreatic neuroendocrine tumors: a review
    Young, Kate
    Iyer, Ridhima
    Morganstein, Daniel
    Chau, Ian
    Cunningham, David
    Starling, Naureen
    FUTURE ONCOLOGY, 2015, 11 (05) : 853 - 864